On November 27, 2024, CD&R Holdings II entered into an agreement (the Master Confirmation
Agreement) with UBS AG, London Branch (UBS), represented by UBS Securities LLC as its agent, pursuant to which CD&R Holdings II has agreed to purchase shares of Common Stock from UBS, as further described in Item 6
below.
Other than as described above or in Item 6, each of the Reporting Persons reports that neither it nor, to its knowledge, any of the other persons
named in Item 2 of this Schedule 13D, currently has any plan or proposal which relates to, or may result in, any of the matters listed in Items 4(a)-(j) of this Schedule 13D, although each Reporting Person expects to evaluate on an ongoing basis the
Issuers financial condition and prospects and its interest in, and intentions with respect to, a variety of transactions that could create shareholder value, including business combinations, acquisitions and refinancing opportunities.
Accordingly, each Reporting Person reserves the right to change its plans and intentions at any time, as it deems appropriate.
In particular, each
Reporting Person may, subject to the limitations set forth in the Investment Agreement (as described below in Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.) and the Master
Confirmation Agreement, at any time and from time to time, in privately negotiated transactions, open market purchases or otherwise, acquire additional or all securities of the Issuer; dispose of all or a portion of the securities of the Issuer that
the Reporting Persons now own or may hereafter acquire; and/or enter into derivative transactions with institutional counterparties with respect to the Issuers securities. The Reporting Persons anticipate that they may purchase shares of
Common Stock in the open market in the near future, subject to market conditions and the terms of the Investment Agreement and the Master Confirmation Agreement. In addition, the Reporting Persons may, subject to the limitations set forth in the
Investment Agreement, engage in discussions with management, the Board, other stockholders of the Issuer and other relevant parties concerning the business, operations, Board composition, management, strategy and future plans of the Issuer. Pursuant
to the Investment Agreement, CD&R Holdings is entitled to designate nominees to the Board, which will afford access to, and participation in, deliberations of the Board regarding the business, operations, Board composition, management, strategy
and future plans of the Issuer.
As a result of these activities, and subject to the limitations set forth in the Investment Agreement, one or more of the
Reporting Persons may suggest or take a position with respect to potential changes in the operations, management, or capital structure of the Issuer as a means of enhancing shareholder value. Such suggestions or positions may include one or more
plans or proposals that relate to or would result in any of the actions required to be reported herein, including, without limitation, such matters as disposing of one or more businesses; selling the Issuer or acquiring another company or business;
changing operating or marketing strategies; adopting, not adopting, modifying, or eliminating certain types of anti-takeover measures; restructuring the Issuers capitalization; reviewing dividend and compensation policies; entering into
agreements with third parties relating to acquisitions of securities issued or to be issued by the Issuer; entering into agreements with the management of the Issuer relating to acquisitions of shares by members of management, issuance of equity
awards to management, or their employment by the Issuer.
Except as described in Item 6 of this Schedule 13D which is incorporated herein by reference,
the Reporting Persons have no present plans or proposals that relate to or would result in any of the actions required to be reported herein.
Item 5. |
Interest in Securities of the Issuer. |
Item 5 of the Schedule 13D is hereby amended by deleting paragraphs (a)(i), (a)(ii) and (c) in their entirety and replacing them as follows.
(a)
(i) CD&R Holdings
is the beneficial owner of 18,517,830 shares of Common Stock on an as-converted basis (based on an initial conversion price of the Preferred Stock of $26.92), which are issuable upon conversion, at
the option of the holder, of 498,500 shares of Preferred Stock that are held directly by CD&R Holdings. Taking into account such securities, the Reporting Persons beneficially own 11.2% of the outstanding shares of Common Stock, based on
(x) the initial conversion price of the Preferred Stock of $26.92 and (y) 146,971,549 shares of Common Stock outstanding as of October 30, 2024, as reported in the Issuers Form 10-Q, filed
November 7, 2024.
(ii) CD&R Holdings II and CD&R Investment Associates may be deemed to beneficially own the reported
securities because CD&R Holdings is wholly owned by CD&R Holdings II and CD&R Investment Associates is the general partner of CD&R Holdings II, but each of CD&R Holdings II and CD&R Investment Associates expressly disclaims
such beneficial ownership. Investment and voting decisions with respect to the reported securities are made by majority vote of an investment committee of limited partners of CD&R Associates that consists of more than ten individuals, each of
whom is also an investment professional of CD&R (the Investment Committee). CD&R Associates may be deemed to beneficially own the reported securities, but expressly disclaims such beneficial ownership. All members of the
Investment Committee expressly disclaim beneficial ownership of the reported securities.
(c) On October 15, 2024, CD&R Holdings
sold 1,500 shares of Preferred Stock to a certain individual, at a price equal to the $1,000 per share liquidation preference, in respect of services provided in connection with CD&R Holdings acquisition of Preferred Stock on June 14,
2024. Except for the foregoing or as otherwise set forth herein, each of the Reporting Persons reports that neither it, nor to its knowledge, any other person named in Item 2 of the Schedule 13D, has effected any transactions in Common Stock or
Preferred Stock during the past 60 days.